BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Transplant. Sep 18, 2026; 16(3): 124992
Published online Sep 18, 2026. doi: 10.5500/wjt.124992
Table 3 Cell type–specific regulated cell death pathways in liver transplantation
Cell type
Dominant cell death pathway
Key mediators
Clinical implications
HepatocytesApoptosis, necrosis, ferroptosis, autophagy, necroptosis, PANoptosis, pyroptosisCaspase -3, caspase-8, caspase-9, Bcl-2 family, GPX4, ACSL4, Slc7A11, RIPK1/RIPK3/MLKL, ZBP1, NF-κB, ROS, DAMPs, NLRP3, GSDMDHepatocellular injury, elevated transaminases, graft dysfunction, EAD
LSEcsFerroptosis, apoptosis, autophagyGPX4, HO-1, caspase-3, ROSEndothelial dysfunction, impaired microcirculation, HIRI, EAD
KCsApoptosis, pyroptosis, necroptosis, PANoptosisNLRP3, ASC, caspase-1, GSDMD, RIPK3, MLKL, cytokines, ROSCytokine storm, inflammatory response, HIRI
CholangiocytesApoptosis, necrosisCaspases, oxidative stress mediatorsBiliary complications
Infiltrated macrophagesPyroptosis, necroptosis, ferroptosisNLRP3, caspase-1, cytokines, ROSInnate inflammatory activation, HIRI
NeutrophilsNETosisROS, NE, MPO, PAD4, GSDMD, DAMPsHIRI, microthrombus formation, acute rejection, EAD, inflammatory response


Write to the Help Desk